erus BioSciences(CHRS) - 2023 Q4 - Earnings Call Transcript

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Results Conference Call March 13, 2024 5:00 PM ET Company Participants Jamie Taylor - Head of Investor Relations Dennis Lanfear - Chief Executive Officer Paul Reider - Chief Commercial Officer Rosh Dias - Chief Medical Officer Theresa LaVallee - Chief Development Officer Bryan McMichael - Interim Chief Financial Officer Conference Call Participants Yigal Nochomovitz - Citigroup Colleen Kusy - Baird Michael Nedelcovych - TD Cowen Ethan Brown - JPMorgan Operator ...